FR2409752A1 - Medicament agissant notamment sur le systeme nerveux central a base d'aryl-2 allophanates d'ethyle - Google Patents

Medicament agissant notamment sur le systeme nerveux central a base d'aryl-2 allophanates d'ethyle

Info

Publication number
FR2409752A1
FR2409752A1 FR7735907A FR7735907A FR2409752A1 FR 2409752 A1 FR2409752 A1 FR 2409752A1 FR 7735907 A FR7735907 A FR 7735907A FR 7735907 A FR7735907 A FR 7735907A FR 2409752 A1 FR2409752 A1 FR 2409752A1
Authority
FR
France
Prior art keywords
aryl
ethyl
nervous system
central nervous
allophanates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7735907A
Other languages
English (en)
Other versions
FR2409752B1 (fr
Inventor
Jesus Anatol
Genevieve Uchida-Ernouf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOISSONNAIS SUCRERIE
Original Assignee
SOISSONNAIS SUCRERIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SOISSONNAIS SUCRERIE filed Critical SOISSONNAIS SUCRERIE
Priority to FR7735907A priority Critical patent/FR2409752A1/fr
Priority to BE191846A priority patent/BE872163A/fr
Priority to GB7845728A priority patent/GB2010812B/en
Priority to LU80573A priority patent/LU80573A1/fr
Priority to NL7811642A priority patent/NL7811642A/xx
Priority to IE2353/78A priority patent/IE47594B1/en
Priority to DE2851495A priority patent/DE2851495C2/de
Priority to IT52098/78A priority patent/IT1107673B/it
Priority to JP53147065A priority patent/JPS606331B2/ja
Priority to CH1218578A priority patent/CH635746A5/fr
Publication of FR2409752A1 publication Critical patent/FR2409752A1/fr
Application granted granted Critical
Publication of FR2409752B1 publication Critical patent/FR2409752B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'INVENTION CONCERNE DES MEDICAMENTS AGISSANT NOTAMMENT SUR LE SYSTEME NERVEUX CENTRAL A BASE D'ARYL-2 ALLOPHANATES D'ETHYLE. ILS SONT A BASE D'UN ARYL-2 ALLOPHANATE D'ETHYLE DE FORMULE GENERALE: (CF DESSIN DANS BOPI) DANS LAQUELLE R, R ET R PEUVENT REPRESENTER DE L'HYDROGENE, DU CHLORE OU DU BROME, UN RADICAL METHYLE -CH OU TRIFLUOROMETHYLE -CF. APPLICATION AUX TROUBLES DU SYSTEME NERVEUX CENTRAL.
FR7735907A 1977-11-29 1977-11-29 Medicament agissant notamment sur le systeme nerveux central a base d'aryl-2 allophanates d'ethyle Granted FR2409752A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR7735907A FR2409752A1 (fr) 1977-11-29 1977-11-29 Medicament agissant notamment sur le systeme nerveux central a base d'aryl-2 allophanates d'ethyle
BE191846A BE872163A (fr) 1977-11-29 1978-11-21 Medicaments agissant notamment sur le systeme nerveux central a base d'aryl-2 allophanates d'ethyle
GB7845728A GB2010812B (en) 1977-11-29 1978-11-23 Medicaments acting notably on the central nervous system based on ethyl 2-aryl allop
LU80573A LU80573A1 (fr) 1977-11-29 1978-11-24 Medicaments agissant notamment sur le systeme nerveux central a base d'aryl-2 allophanates d'ethyle
NL7811642A NL7811642A (nl) 1977-11-29 1978-11-27 Op het centrale zenuwstel werkend geneesmiddel.
IE2353/78A IE47594B1 (en) 1977-11-29 1978-11-28 Medicaments acting notably on the central nervous system based on ethyl 2-aryl allophanates
DE2851495A DE2851495C2 (de) 1977-11-29 1978-11-28 Pharmazeutisches Mittel mit Wirkung auf das Zentralnervensystem auf der Basis von Äthyl-2-phenyl-allophanaten
IT52098/78A IT1107673B (it) 1977-11-29 1978-11-28 Medicamento a base di aril-2-allofanati etilici che agisce in particolare sul sistema nervoso centrale
JP53147065A JPS606331B2 (ja) 1977-11-29 1978-11-28 エチル２−アリ−ル−アロフアネ−トに基づく主として中枢神経系に作用する薬剤
CH1218578A CH635746A5 (fr) 1977-11-29 1978-11-28 Medicament agissant sur le systeme nerveux central, a base d'aryl-2 allophanate d'ethyle.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7735907A FR2409752A1 (fr) 1977-11-29 1977-11-29 Medicament agissant notamment sur le systeme nerveux central a base d'aryl-2 allophanates d'ethyle

Publications (2)

Publication Number Publication Date
FR2409752A1 true FR2409752A1 (fr) 1979-06-22
FR2409752B1 FR2409752B1 (fr) 1982-11-12

Family

ID=9198212

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7735907A Granted FR2409752A1 (fr) 1977-11-29 1977-11-29 Medicament agissant notamment sur le systeme nerveux central a base d'aryl-2 allophanates d'ethyle

Country Status (10)

Country Link
JP (1) JPS606331B2 (fr)
BE (1) BE872163A (fr)
CH (1) CH635746A5 (fr)
DE (1) DE2851495C2 (fr)
FR (1) FR2409752A1 (fr)
GB (1) GB2010812B (fr)
IE (1) IE47594B1 (fr)
IT (1) IT1107673B (fr)
LU (1) LU80573A1 (fr)
NL (1) NL7811642A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2572726A1 (fr) * 1984-11-08 1986-05-09 Francaise Sucrerie Phenyl-2 allophanate d'isopropyle, son procede d'obtention et son application dans le domaine pharmaceutique
WO2026057953A1 (fr) 2024-09-13 2026-03-19 Lesaffre Et Compagnie Synthese d'ethanol par hydrogenation de dioxyde de carbone

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2572726A1 (fr) * 1984-11-08 1986-05-09 Francaise Sucrerie Phenyl-2 allophanate d'isopropyle, son procede d'obtention et son application dans le domaine pharmaceutique
EP0187057A1 (fr) * 1984-11-08 1986-07-09 Compagnie Francaise De Sucrerie Phényl-2 allophanate d'isopropyle, son procédé d'obtention et son application dans le domaine pharmaceutique
WO2026057953A1 (fr) 2024-09-13 2026-03-19 Lesaffre Et Compagnie Synthese d'ethanol par hydrogenation de dioxyde de carbone

Also Published As

Publication number Publication date
GB2010812B (en) 1982-05-19
JPS606331B2 (ja) 1985-02-18
IE782353L (en) 1979-05-29
JPS5492939A (en) 1979-07-23
CH635746A5 (fr) 1983-04-29
FR2409752B1 (fr) 1982-11-12
LU80573A1 (fr) 1979-06-15
BE872163A (fr) 1979-05-21
IT7852098A0 (it) 1978-11-28
DE2851495C2 (de) 1982-06-24
NL7811642A (nl) 1979-05-31
IT1107673B (it) 1985-11-25
DE2851495A1 (de) 1979-05-31
GB2010812A (en) 1979-07-04
IE47594B1 (en) 1984-05-02

Similar Documents

Publication Publication Date Title
BE867692A (fr) Dispositif fournissant une liberation entretenue d'un medicament.
DE69127470D1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
NO954694L (no) Doseringsform for antidepressiva
HN1997000052A (es) Nuevas 4(3h)--quinazolinas 2,3-disustituidas
CA2339934A1 (fr) Medicaments contre la sclerose en plaques
BG104727A (en) Pharmaceutical composition of topiramate
FR2364656A1 (fr) Medicament anti-tumeur a base de compose du type lysolecithine
ATE214277T1 (de) Schmerzlindernde arzneistoffzusammensetzung
DK0835126T3 (da) Sammensætninger og formuleringer til fremstilling af analgesimidler og til hamning af fremadskridende neuropatiske amertelidelser
DK515489A (da) Dispergerbar laegemiddelformulering
FR2444671A1 (fr) Nouvelles quinazolinones, leur preparation et medicament contenant ces substances
GR78987B (fr)
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
FR2370737A1 (fr) Imidazole-carboxamides substitues a l'azote, leur obtention et composition pharmaceutique en contenant
FR2409752A1 (fr) Medicament agissant notamment sur le systeme nerveux central a base d'aryl-2 allophanates d'ethyle
SE9303853D0 (sv) The use of an ester of inositoltrisphosphate for the preparing of medicaments
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ATE71385T1 (de) Arzneimittel zur therapie von durch funktionelle und organische basen verursachten gehirnkrankheiten.
BE904605A (fr) Hydroxy-1 acyloxy-8 acyl-10 anthrones, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique.
DK162471C (da) Suge- eller tyggetablet
FR2384794A1 (fr) Methylene-1a,2a steroides et medicaments qui en contiennent
FR2447368A1 (fr) Derives de la phenylethylamine, leur preparation et medicament contenant ces substances
ATE169819T1 (de) (-)-metrifonat enthaltendes arzneimittel
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
FR2706303B1 (fr) Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.

Legal Events

Date Code Title Description
ST Notification of lapse